JP2014527040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527040A5 JP2014527040A5 JP2014521801A JP2014521801A JP2014527040A5 JP 2014527040 A5 JP2014527040 A5 JP 2014527040A5 JP 2014521801 A JP2014521801 A JP 2014521801A JP 2014521801 A JP2014521801 A JP 2014521801A JP 2014527040 A5 JP2014527040 A5 JP 2014527040A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- pharmaceutical composition
- seq
- composition according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509340P | 2011-07-19 | 2011-07-19 | |
| US61/509,340 | 2011-07-19 | ||
| US201261662337P | 2012-06-20 | 2012-06-20 | |
| US61/662,337 | 2012-06-20 | ||
| PCT/US2012/047468 WO2013013085A2 (en) | 2011-07-19 | 2012-07-19 | Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014527040A JP2014527040A (ja) | 2014-10-09 |
| JP2014527040A5 true JP2014527040A5 (enExample) | 2015-08-20 |
Family
ID=47558730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521801A Pending JP2014527040A (ja) | 2011-07-19 | 2012-07-19 | 抗−線維化ペプチド並びに線維化を特徴とする疾患及び障害を治療するための方法における該抗−線維化ペプチドの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140057831A1 (enExample) |
| EP (1) | EP2734220A4 (enExample) |
| JP (1) | JP2014527040A (enExample) |
| CN (2) | CN103890003B (enExample) |
| AU (1) | AU2012283924A1 (enExample) |
| BR (1) | BR112014001268A2 (enExample) |
| CA (1) | CA2842330A1 (enExample) |
| HK (1) | HK1198333A1 (enExample) |
| IL (1) | IL230510A0 (enExample) |
| RU (1) | RU2014105513A (enExample) |
| WO (1) | WO2013013085A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016054155A1 (en) * | 2014-09-30 | 2016-04-07 | Primegen Biotech, Llc. | Treatment of fibrosis using deep tissue heating and stem cell therapy |
| WO2016077539A1 (en) * | 2014-11-12 | 2016-05-19 | Thrasos Innovation, Inc. | Peptides with enhanced stability and their use in methods for treating diseases |
| US11466255B2 (en) | 2015-05-01 | 2022-10-11 | University Of Miami | Methods and compositions for converting non-endocrine pancreatic tissue into insulin-producing cells |
| CN114181281A (zh) * | 2015-05-12 | 2022-03-15 | 加利福尼亚大学董事会 | 用于炎症和纤维化的肽治疗 |
| JP6952685B2 (ja) * | 2015-06-05 | 2021-10-20 | アイバイオ・インコーポレイテッドＩｂｉｏ， Ｉｎｃ． | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
| WO2019133950A1 (en) * | 2017-12-30 | 2019-07-04 | The Regents Of The University Of Colorado, A Body Corporate | Smad7 for treatment and prevention of posterior capsule opacification |
| JP6933394B2 (ja) * | 2018-09-06 | 2021-09-08 | マリン エッセンス バイオサイエンシズ コーポレーション オブ ユーエスエーＭａｒｉｎｅ Ｅｓｓｅｎｃｅ Ｂｉｏｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ ｏｆ ＵＳＡ | 組織再生誘導のためのバイオマテリアルデバイスおよび局所用組成物 |
| WO2020086580A1 (en) * | 2018-10-22 | 2020-04-30 | Carlson William D | Therapeutic combinations of tdfrps and additional agents and methods of use |
| US20210008173A1 (en) * | 2019-07-10 | 2021-01-14 | Musc Foundation For Research Development | Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury |
| CN111704653B (zh) * | 2020-06-08 | 2023-10-03 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
| WO2022197855A1 (en) * | 2021-03-16 | 2022-09-22 | Therapeutics By Design, LLC | Therapeutic combinations of tdfrps and additional agents and methods of use for the reversal of fibrosis |
| CN113069531B (zh) * | 2021-04-09 | 2023-02-28 | 南开大学 | 一种防疤痕皮肤创伤修复用水凝胶及其制备方法 |
| CN116768974A (zh) * | 2022-03-11 | 2023-09-19 | 中山大学 | 用于预防和/或治疗肾纤维化的多肽化合物 |
| WO2024081245A1 (en) | 2022-10-10 | 2024-04-18 | Therapeutics By Design, LLC | Tissue differentiation factor related polypeptides (tdfrps) for the treatment of myocardial injury |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69723429T3 (de) * | 1996-03-22 | 2007-09-20 | Curis, Inc., Cambridge | Verfahren zur verbesserten funktionellen Erholung der motorischen Koordination, der Sprache oder Sinneswahrnehmung nach Trauma oder Ischämie des ZNS |
| JP4654029B2 (ja) * | 2002-06-17 | 2011-03-16 | トラソス インコーポレイテッド | 単一ドメインｔｄｆ関連化合物およびその類似体 |
| CA2897218A1 (en) * | 2004-06-17 | 2006-01-26 | Thrasos Innovation, Inc. | Tdf-related compounds and analogs thereof |
| PT2497780E (pt) * | 2005-09-20 | 2015-08-20 | Thrasos Innovation Inc | Compostos relacionados com tdf e seus análogos |
| US20110275574A1 (en) * | 2009-01-16 | 2011-11-10 | Agency For Science, Technology And Research | Method of inhibiting proliferation of hepatic stellate cells |
| US8642834B2 (en) * | 2009-02-27 | 2014-02-04 | OSI Pharmaceuticals, LLC | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| US20120183543A1 (en) * | 2009-05-08 | 2012-07-19 | Novartis Ag | Diagnostic biomarkers for fibrotic disorders |
-
2012
- 2012-07-19 US US13/553,685 patent/US20140057831A1/en not_active Abandoned
- 2012-07-19 RU RU2014105513/04A patent/RU2014105513A/ru not_active Application Discontinuation
- 2012-07-19 WO PCT/US2012/047468 patent/WO2013013085A2/en not_active Ceased
- 2012-07-19 JP JP2014521801A patent/JP2014527040A/ja active Pending
- 2012-07-19 CN CN201280045650.7A patent/CN103890003B/zh not_active Expired - Fee Related
- 2012-07-19 HK HK14111848.5A patent/HK1198333A1/zh unknown
- 2012-07-19 EP EP12814119.9A patent/EP2734220A4/en not_active Withdrawn
- 2012-07-19 AU AU2012283924A patent/AU2012283924A1/en not_active Abandoned
- 2012-07-19 BR BR112014001268A patent/BR112014001268A2/pt not_active IP Right Cessation
- 2012-07-19 CN CN201610543024.0A patent/CN106478776A/zh active Pending
- 2012-07-19 CA CA2842330A patent/CA2842330A1/en not_active Abandoned
-
2014
- 2014-01-16 IL IL230510A patent/IL230510A0/en unknown
-
2015
- 2015-08-05 US US14/818,652 patent/US20160058829A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014105513A (ru) | Противофиброзные пептиды и их применение в способах лечения заболеваний и расстройств, характеризующихся фиброзом | |
| JP2013520405A5 (enExample) | ||
| JP2015517488A5 (enExample) | ||
| HRP20200889T1 (hr) | Upotreba dugodjelujućih peptida glp-1 | |
| JP2015517489A5 (enExample) | ||
| JP2015518818A5 (enExample) | ||
| JP2014508753A5 (enExample) | ||
| JP2015057436A5 (enExample) | ||
| JP2012092110A5 (enExample) | ||
| JP2011528332A5 (enExample) | ||
| HRP20180425T1 (hr) | Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline | |
| EA201491245A1 (ru) | Новые дигидропиримидинизохинолиноны и содержащие их фармацевтические композиции для лечения воспалительных нарушений | |
| JP2013542247A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| NZ708501A (en) | Treatment of pulmonary disease | |
| JP2013509429A5 (enExample) | ||
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| JP2015513318A5 (enExample) | ||
| JP2011509303A5 (enExample) | ||
| JP2016534153A5 (enExample) | ||
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| JP2015526391A5 (enExample) | ||
| JP2014529399A5 (enExample) | ||
| JP2012529293A5 (enExample) |